Photo: Courtesy of Teva
Teva has agreed to sell certain assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, Actavis Generics, Accord Healthcare, mergers and acquisitions, European Commission